BioCentury | Jan 8, 2007
Strategy

Thinking globally

...and inflammation pSivida (ASX:PSD; PSDV) Acquired 100% stake in U.K. subsidiary pSiMedica from JV partner QinetiQ...
BioCentury | Nov 7, 2005
Clinical News

BrachySil: Phase IIb started

...be followed for up to 12 months after treatment. pSivida Ltd. (ASX:PSD; PSDV), Perth, Australia QinetiQ Ltd....
BioCentury | Feb 21, 2005
Clinical News

BrachySil: Phase IIa data

...tumor regression in the first cohort of 4 patients. pSivida Ltd. (ASX:PSD; PSDV), Perth, Australia QinetiQ Ltd....
BioCentury | Jun 7, 2004
Company News

pSivida Ltd., QinetiQ deal

...all of the shares of pSiMedica Ltd. that is doesn’t currently own from JV partner QinetiQ...
...pay AUS$4.3 million in cash and issue a total of 49.1 million shares at AUS$1.09. QinetiQ...
...developing its BioSilicon technology platform for use in drug delivery, tissue engineering and clinical diagnostics. QinetiQ...
BioCentury | Jun 7, 2004
Company News

pSivida Ltd. board of directors update

...Ltd. (ASX:PSD; FSE:PSI), Perth, Australia Business: Drug delivery, Diagnostic Appointed: Stephen Lake, investment director of QinetiQ WIR...
Items per page:
1 - 5 of 5
BioCentury | Jan 8, 2007
Strategy

Thinking globally

...and inflammation pSivida (ASX:PSD; PSDV) Acquired 100% stake in U.K. subsidiary pSiMedica from JV partner QinetiQ...
BioCentury | Nov 7, 2005
Clinical News

BrachySil: Phase IIb started

...be followed for up to 12 months after treatment. pSivida Ltd. (ASX:PSD; PSDV), Perth, Australia QinetiQ Ltd....
BioCentury | Feb 21, 2005
Clinical News

BrachySil: Phase IIa data

...tumor regression in the first cohort of 4 patients. pSivida Ltd. (ASX:PSD; PSDV), Perth, Australia QinetiQ Ltd....
BioCentury | Jun 7, 2004
Company News

pSivida Ltd., QinetiQ deal

...all of the shares of pSiMedica Ltd. that is doesn’t currently own from JV partner QinetiQ...
...pay AUS$4.3 million in cash and issue a total of 49.1 million shares at AUS$1.09. QinetiQ...
...developing its BioSilicon technology platform for use in drug delivery, tissue engineering and clinical diagnostics. QinetiQ...
BioCentury | Jun 7, 2004
Company News

pSivida Ltd. board of directors update

...Ltd. (ASX:PSD; FSE:PSI), Perth, Australia Business: Drug delivery, Diagnostic Appointed: Stephen Lake, investment director of QinetiQ WIR...
Items per page:
1 - 5 of 5